Screener
Aclaris Therapeutics ACRS Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Total other income | 2,733 | 2,979 | 5,101 | 5,978 |
| Net loss | $(21,505) | $(15,429) | $(41,329) | $(30,514) |
| Net loss per share, basic and diluted | $(0.15) | $(0.13) | $(0.30) | $(0.25) |
| Weighted average common shares outstanding, basic and diluted | 142,736,848 | 122,580,967 | 135,811,921 | 122,486,162 |
| Other comprehensive (loss) income: | ||||
| Unrealized (loss) gain on marketable securities, net of tax of $0 | $(326) | $48 | $(914) | $385 |
| Total other comprehensive (loss) income | (326) | 48 | (914) | 385 |
| Comprehensive loss | $(21,831) | $(15,381) | $(42,243) | $(30,129) |
Item 1. Financial Statements
FAQ
- What is Aclaris Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Aclaris Therapeutics (ACRS) reported comprehensive income (loss), net of tax, attributable to parent of -$21.83M in Q2 2026.
- How has Aclaris Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Aclaris Therapeutics's comprehensive income (loss), net of tax, attributable to parent decreased by 41.9% year-over-year, from -$15.38M to -$21.83M.
- What is the long-term trend for Aclaris Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Aclaris Therapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a -8.3% compound annual growth rate (CAGR), from -$91M to -$64.41M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- Represents the total change in the company's net assets from non-owner sources, combining net income with other comprehensive income items. This figure provides a comprehensive view of the company's total financial health and the impact of both operational performance and external market factors. Investors use this to understand the full scope of changes in the company's equity position over the reporting period.
Ask your AI about Aclaris Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude